Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors.
about
Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Clinical Outcomes Related to t ...... ugs and Proteasome Inhibitors.
@en
type
label
Clinical Outcomes Related to t ...... ugs and Proteasome Inhibitors.
@en
prefLabel
Clinical Outcomes Related to t ...... ugs and Proteasome Inhibitors.
@en
P2093
P2860
P356
P1476
Clinical Outcomes Related to t ...... ugs and Proteasome Inhibitors.
@en
P2093
Ayşe Salihoğlu
Fevzi Fırat Yalnız
Nihan Akkoç
Teoman Soysal
Yıldız Aydın
Şeniz Öngören
P2860
P304
P356
10.4274/TJH.2016.0397
P577
2017-03-08T00:00:00Z